Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RITA Medical/Boston Scientific

This article was originally published in The Gray Sheet

Executive Summary

Radiofrequency ablation technology cross-license settles all pending patent disputes between the firms. Under the terms of the deal, which does not include RITA temperature control technology, RITA will make a $2.7 mil. one-time payment to the Universities of Kansas and Nebraska, which own some of the related Boston Scientific patents. BSC filed a claim against RITA's StarBurst line in northern California federal court in April 2002 after RITA filed suit against its RadioTherapeutics unit in August 2001 (1"The Gray Sheet" April 29, 2002, p. 20)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018208

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel